Clinical trials
Active, not recruiting Macular Degeneration trials in the United States
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
26 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2008 | 1 |
| 2011 | 1 |
| 2012 | 1 |
| 2015 | 1 |
| 2020 | 2 |
| 2021 | 1 |
| 2022 | 6 |
| 2023 | 6 |
| 2024 | 2 |
| 2025 | 5 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Active, not recruiting | 26 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| AbbVie | 2 |
| Adverum Biotechnologies, Inc. | 2 |
| Chengdu Origen Biotechnology Co., Ltd. | 2 |
| 4D Molecular Therapeutics | 1 |
| Astellas Pharma Global Development, Inc. | 1 |
| Boehringer Ingelheim | 1 |
| ClinOmicsAI | 1 |
| Complement Therapeutics | 1 |
| Elisigen, Inc. | 1 |
| Exegenesis Bio | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Macular Degeneration | 26 |
| Wet Macular Degeneration | 8 |
| Geographic Atrophy | 7 |
| Choroidal Neovascularization | 6 |
| Eye Diseases | 6 |
| Retinal Degeneration | 5 |
| Retinal Diseases | 5 |
| Blindness | 2 |
| Anetoderma | 1 |
| Blindness, Cortical | 1 |
Trials
Showing 1 to 25 of 26. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.